Foghorn Therapeutics Inc.FHTXNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank57
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-4.58
↑ 37% vs avg
Percentile
P57
Within normal range
Streak
3 yr
Consecutive declineElevated
Average
-7.32
Historical baseline
PeriodValueYoY Change
2025-4.58-53.0%
2024-2.99-8.8%
2023-2.75-12.9%
2022-2.44+71.0%
2021-8.39+22.6%
2020-10.84+16.9%
2019-13.05+3.4%
2018-13.51-